- Clinical Trials
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£962GBP
- Report
- August 2025
- 180 Pages
Global
From €3495EUR$3,939USD£3,033GBP
- Report
- October 2025
- 500 Pages
Global
From €3545EUR$3,995USD£3,076GBP
- Report
- January 2026
- 194 Pages
Global
From €3495EUR$3,939USD£3,033GBP
- Report
- January 2026
- 190 Pages
Global
From €3495EUR$3,939USD£3,033GBP
- Report
- April 2025
- 220 Pages
Global
From €3394EUR$3,825USD£2,945GBP
€3993EUR$4,500USD£3,465GBP
- Report
- June 2025
- 147 Pages
Global
From €4348EUR$4,900USD£3,773GBP
- Report
- August 2025
- 198 Pages
Global
From €3495EUR$3,939USD£3,033GBP
- Report
- January 2026
- 367 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 386 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 282 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 483 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 485 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 477 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- January 2026
- 376 Pages
Global
From €5191EUR$5,850USD£4,504GBP
- Report
- September 2025
- 250 Pages
Global
From €3984EUR$4,490USD£3,457GBP
- Report
- September 2025
- 250 Pages
Global
From €3984EUR$4,490USD£3,457GBP
- Report
- September 2025
- 250 Pages
Global
From €3984EUR$4,490USD£3,457GBP
- Report
- July 2025
- 175 Pages
Global
From €3984EUR$4,490USD£3,457GBP
- Report
- July 2025
- 175 Pages
Global
From €3984EUR$4,490USD£3,457GBP

Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease.
CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions.
The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more